in a double-blind , randomised group comparative study the efficacy of daily oral administration of 100 mg and 200 mg torasemide ( 1-isopropyl-3- ( [ 4- ( 3-methyl-phenylamino ) pyridine ] -3-sulfonyl ) urea ) were compared with that of 250 mg furosemide over 2 weeks in patients with advanced chronic renal failure , who had been pretreated with a maintenance therapy of 500 mg furosemide per day .
C0016860
furosemide
C0022661
chronic renal failure